CTLT has formed a distinctive double bottom pattern on the weekly scale subsequent to the emergence of a bullish divergence. Notably, it has recently breached the neckline of this formation and is presently trading above it. The outlook for CTLT appears promising, with potential for further upside momentum. Longer-term projections suggest the possibility of...
Main Highlights 1. Syringe maker Catalent suggested soaring demand for injectable weight-loss drugs could lead to sizable revenue gains, and shares surged. 2. The company said sales of its pre-filled syringes could increase more than five-fold because of the popularity of those drugs. 3. Catalent also released preliminary quarterly results, and revenue exceeded...
31.70 is our strong support point. We need closes above the wedge indicator for the movement to accelerate upwards. We can accept the wedge indicator as a follower.
Analyzing the options chain and the chart patterns of CTLT Catalent prior to the earnings report this week, I would consider purchasing the 40usd strike price in the money Calls with an expiration date of 2024-1-19, for a premium of approximately $8.30. If these options prove to be profitable prior to the earnings release, I would sell at least half of...
NYSE:CTLT could attemp to the fill the closest gap. but in long run i believe a retest of low and the liquidity around 30$ range has to be collected.
Price on this daily chart is currently within a down channel. However price is close to the bottom of the down channel. I expect a W like recovery from this bottom, which shows with the bars pattern tool in green. Similar down periods in green lines also.
Catalent - 30d expiry - We look to Sell a break of 65.98 (stop at 69.98) We have a Gap open at 6.2. from 56.05 to 69.46. The primary trend remains bearish. A break of support at 66.44 should lead to a more aggressive move lower towards 55.00. This stock has seen poor sales growth. Our outlook is bearish. Our profit targets will be 55.98 and 53.98...
The PEAD projected a Bearish outlook for $CTLT after a Negative Under reaction following its earnings release placing the stock in drift D.
Catalent Short Term - We look to Buy at 63.84 (stop at 56.95) The primary trend remains bearish. Bespoke support is located at 63.30. Support could prove difficult to breakdown. We look for a temporary move lower. Preferred trade is to buy on dips. Our profit targets will be 82.27 and 88.00 Resistance: 82.50 / 100.00 / 120.00 Support: 63.30 / 48.00 /...
He must break the enemy. Let's look for closure where I specified with X. wedge indicator resistance on weekly timeframe The targets were determined according to Fibonacci.
Short (Entry Price) below the black line and exit (Stop Loss) above the red line. Can take profit at the suggested Target Price. Entry Price: $102.46 Target Price: $100.18 Stop Loss: $104.74
The PEAD projected a Bullish outlook for $CTLT after a Positive Under reaction following its earnings release placing the stock in drift A with an expected accuracy of 50%.
Based on its downtrend, regress off resistance and a familiar chart pattern confirmed by my technical indicators, I expect at least half a percent in profits IF CTLT breaches Friday's low of $96.58 during tomorrow's session.
CTLT Broke out of 8 Month Long Rectangle Pattern 200 DMA Holding Dips Breakout happened with more than average volume
CTLT looking bullish after a double bottom right on the 200 EMA. Also has a nice MACD pattern. Will buy now or keep a close eye on it for a retracement bar to use for an entry.
Now I've been watching Catalent, since they partnered up with one of the stocks I hold for a COVID treatment. Novan. Doing a quick glance at CTLT I noticed a TA pattern known as a double bottom and with certain catalyst coming out, maybe its about to run up and leave this bearish trend. News -ER is in 14 days -They have partnered up with Novan to design the...
➡️Pattern recognized: Running flat Elliot correction wave ➡️Hypothesis: Bullish on health care ➡️Inter-market analysis: XLC👇 ➡️Catalyst: Earnings in 40 days, and XLV still looking bullish. ➡️Conclusion: Prepared to buy calls If you like what you see why not support us? 👇